285 related articles for article (PubMed ID: 31126637)
1. Ultrastaging of negative pelvic lymph nodes to decrease the true prevalence of isolated paraaortic dissemination in endometrial cancer.
Multinu F; Casarin J; Cappuccio S; Keeney GL; Glaser GE; Cliby WA; Weaver AL; McGree ME; Angioni S; Faa G; Leitao MM; Abu-Rustum NR; Mariani A
Gynecol Oncol; 2019 Jul; 154(1):60-64. PubMed ID: 31126637
[TBL] [Abstract][Full Text] [Related]
2. Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer.
Touhami O; Grégoire J; Renaud MC; Sebastianelli A; Plante M
Gynecol Oncol; 2017 Dec; 147(3):549-553. PubMed ID: 28942993
[TBL] [Abstract][Full Text] [Related]
3. The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes.
Abu-Rustum NR; Gomez JD; Alektiar KM; Soslow RA; Hensley ML; Leitao MM; Gardner GJ; Sonoda Y; Chi DS; Barakat RR
Gynecol Oncol; 2009 Nov; 115(2):236-8. PubMed ID: 19666190
[TBL] [Abstract][Full Text] [Related]
4. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.
Zahl Eriksson AG; Ducie J; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Abu-Rustum NR; Mariani A; Leitao MM
Gynecol Oncol; 2016 Mar; 140(3):394-9. PubMed ID: 26747778
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion.
Kim CH; Khoury-Collado F; Barber EL; Soslow RA; Makker V; Leitao MM; Sonoda Y; Alektiar KM; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2013 Dec; 131(3):714-9. PubMed ID: 24099838
[TBL] [Abstract][Full Text] [Related]
6. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
[TBL] [Abstract][Full Text] [Related]
7. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
[TBL] [Abstract][Full Text] [Related]
8. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node intraoperative analysis in endometrial cancer.
Bellaminutti S; Bonollo M; Gasparri ML; Clivio L; Migliora P; Mazzucchelli L; Papadia A
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3199-3205. PubMed ID: 32815026
[TBL] [Abstract][Full Text] [Related]
10. Ultrastaging of para-aortic lymph nodes in stage IIIC1 endometrial cancer: a preliminary report.
Todo Y; Suzuki Y; Azuma M; Hatanaka Y; Konno Y; Watari H; Kato H; Matsuno Y; Yamashiro K; Sakuragi N
Gynecol Oncol; 2012 Dec; 127(3):532-7. PubMed ID: 22940490
[TBL] [Abstract][Full Text] [Related]
11. Ultrastaging of 'negative' pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences.
Gill SE; Garzon S; Multinu F; Hokenstad AN; Casarin J; Cappuccio S; McGree ME; Weaver AL; Cliby WA; Keeney GL; Mariani A
Int J Gynecol Cancer; 2021 Dec; 31(12):1541-1548. PubMed ID: 34706876
[TBL] [Abstract][Full Text] [Related]
12. FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem?
Papadia A; Gasparri ML; Siegenthaler F; Imboden S; Mohr S; Mueller MD
J Cancer Res Clin Oncol; 2017 Mar; 143(3):491-497. PubMed ID: 27834005
[TBL] [Abstract][Full Text] [Related]
13. Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.
El-Agwany AS; Meleis MH
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():35-39. PubMed ID: 29660577
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease.
Ducie JA; Eriksson AGZ; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Soslow RA; Keeney GL; Abu-Rustum NR; Mariani A; Leitao MM
Gynecol Oncol; 2017 Dec; 147(3):541-548. PubMed ID: 28965698
[TBL] [Abstract][Full Text] [Related]
15. Sentinel Lymph Node Mapping in Endometrial Cancer: An Update.
Khoury-Collado F; St Clair C; Abu-Rustum NR
Oncologist; 2016 Apr; 21(4):461-6. PubMed ID: 26961924
[TBL] [Abstract][Full Text] [Related]
16. Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer.
Kumar S; Podratz KC; Bakkum-Gamez JN; Dowdy SC; Weaver AL; McGree ME; Cliby WA; Keeney GL; Thomas G; Mariani A
Gynecol Oncol; 2014 Jan; 132(1):38-43. PubMed ID: 24120926
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for paraaortic lymph node metastasis in endometrial cancer.
Sari ME; Yalcin İ; Sahin H; Meydanli MM; Gungor T
Int J Clin Oncol; 2017 Oct; 22(5):937-944. PubMed ID: 28523533
[TBL] [Abstract][Full Text] [Related]
18. Combination of sentinel lymph node mapping and uterine frozen section examination to reduce side-specific lymphadenectomy rate in endometrial cancer: a Turkish Gynecologic Oncology Group study (TRSGO-SLN-002).
Altin D; Taşkın S; Kahramanoglu I; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Naki MM; Güngör M; Köse MF; Ortac F; Arvas M; Ayhan A; Taskiran C
Int J Gynecol Cancer; 2020 Jul; 30(7):1005-1011. PubMed ID: 32474451
[TBL] [Abstract][Full Text] [Related]
19. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes.
Barlin JN; Khoury-Collado F; Kim CH; Leitao MM; Chi DS; Sonoda Y; Alektiar K; DeLair DF; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2012 Jun; 125(3):531-5. PubMed ID: 22366409
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
